Culturally tailored asthma intervention for Hispanic children
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children
This study tests a new app called Asthma Guardian to see if it helps Hispanic children aged 5-12 with uncontrolled asthma feel better and manage their condition more effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 5 Years to 12 Years |
| Sex | All |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Trial ID | NCT05892302 on ClinicalTrials.gov |
What this trial studies
This pilot trial evaluates a culturally tailored, app-based asthma intervention called Asthma Guardian for Hispanic children aged 5-12 with uncontrolled asthma. The study compares the effects of immediate access to the intervention against delayed access, focusing on reducing asthma morbidity through education, specialist care support, and environmental interventions. Families will engage with a virtual community health worker for personalized support and resources via a web-based platform. The trial aims to inform future larger efficacy studies based on its findings.
Who should consider this trial
Good fit: Ideal candidates are Mexican American or Hispanic children aged 5-12 with persistent asthma and a history of exacerbations.
Not a fit: Patients who do not identify as Mexican American or Hispanic, or those without persistent asthma, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve asthma management and health outcomes for Hispanic children.
How similar studies have performed: Other studies have shown promise in culturally tailored interventions for asthma management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Provision of signed and dated informed consent forms.
2. Who has a child who is 5-12 years of age
3. Whose child meets criteria for current persistent asthma defined as either:
1. On a long-term controller medication for asthma, or
2. Meet NAEPP guideline requirements for persistent disease:)(35)
* Asthma symptoms 3 or more days per week over the past 2 weeks OR
* Nocturnal asthma symptoms at least 3 times in the past month
4. Whose child has had an asthma exacerbation, defined as an oral steroid burst, in the previous 12 months
5. Parent/Caregiver identifies as Mexican American or other Hispanic descent
6. Whose child has clinician diagnosed asthma
7. Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart phone, internet access)
8. Whose child is not currently participating in another asthma study.
The parent/caregiver is the primary study participant, but the child will be asked to complete some surveys at baseline and six months, so an assent will be obtained from the child.
Exclusion Criteria:
* An individual who meets any of the following criteria will be excluded from participation in this study:
1. Unwilling to provide consent for research activities
2. Cognitive inability to provide consent
3. Whose child has evidence of other chronic lung or significant cardiovascular disease
4. Whose child has a history of intubation for asthma
Where this trial is running
Austin, Texas
- University of Texas at Austin — Austin, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Elizabeth Matsui, MD — University of Texas at Austin
- Study coordinator: Susan Balcer Whaley, MPH
- Email: susan.balcerwhaley@austin.utexas.edu
- Phone: 443-824-6107
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.